The G protein-coupled receptor GPR89A is a novel potential therapeutic target to overcome cisplatin resistance in NSCLC Calu1 cells.
G 蛋白偶联受体 GPR89A 是一种新型的潜在治疗靶点，可用于克服 NSCLC Calu1 细胞的顺铂耐药性
期刊:FEBS Journal
影响因子:4.2
doi:10.1111/febs.70099
Guler Kara Hale, Dogan Eda, Bozok Vildan, Aktan Cagdas, Cakiroglu Ece, Eroglu Zuhal, Aygunes Jafari Duygu, Korkmaz Kemal Sami, Senturk Serif, Kosova Buket
